Business UpdateMay 21, 2026, 04:07 PM
Cue Biopharma CEO to Present at Jefferies Global Healthcare Conference
AI Summary
Cue Biopharma, Inc. announced that its President and CEO, Shao-Lee Lin, will present at the Jefferies Global Healthcare Conference on June 3, 2026. The presentation will cover the company's progress in developing transformative therapies for immunological disorders, including its lead anti-IgE antibody in Phase 2 development and its autoimmune candidate CUE-401 advancing towards Phase 1. A live webcast and replay will be available for investors.
Key Highlights
- Cue Biopharma President and CEO, Shao-Lee Lin, to present at Jefferies Global Healthcare Conference.
- Presentation scheduled for Wednesday, June 3, 2026, at 3:10 p.m. EDT.
- Event will take place in New York City.
- A live audio webcast and replay will be available on Cue Biopharma's Investor Relations website.
- Webcast replay will be archived for 90 days.
- Cue Biopharma is a clinical-stage therapeutics company focused on immunological disorders.
- Company's lead asset is a novel anti-IgE antibody in Phase 2 for allergic diseases.
- Lead autoimmune candidate, CUE-401, is advancing towards Phase 1.
Price Impact
More from CUE